Skip to Content
Søg Menu
Vi dækker

SABCS | San Antonio Breast Cancer Symposium

SABCS 2025

SABCS 2025: Favorable Benefit–Risk Profile of Sacituzumab Govitecan in Previously Untreated Metastatic TNBC PD-L1–ineligible Metastatic Triple-Negative Breast Cancer

/ Jan Andreasen
NBCNSABCS25Brystcancer
Kirsten Marie Woolpert

SABCS 2025: Patterns of Opioid Use Among Breast Cancer Survivors

/ Kirsten Marie Woolpert
NBCNSABCS25Brystcancer Play the Video

SABCS 2024

Demet Özcan

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

/ Demet Özcan
SABCS24Brystcancer Play the Video
Adam Brufsky

SABCS 2024: Palbociclib, Abemaciclib, and Ribociclib Can Be Considered Equivalent in the Treatment of HR-positive/HER2-negative Metastatic Breast Cancer

/ Adam Brufsky
SABCS24Brystcancer Play the Video

SABCS 2023

Hatem Azim

Using Fertility Options May be Safe for Patients with HR-positive Breast Cancer

/ Hatem Azim
SABCS23Brystcancer Play the Video

SABCS 2023: HR-Positive Breast Cancer Patients May Safely Use Fertility Options

/ BestPractice Nordic
SABCS23Brystcancer
Terry Mamounas

The Effectiveness of Regional Nodal Radiation in Patients with Breastcancer

/ Eleftherios (Terry) P. Mamounas
SABCS23Brystcancer Play the Video

SABCS 2023: Younger Postmenopausal Women May Safely Skip Adjuvant Radiotherapy

/ BestPractice Nordic
SABCS23Brystcancer

SABCS 2023: Neoadjuvant Chemotherapy May Reduce Regional Nodal Irradiation in Breast Cancer Patients

/ BestPractice Nordic
SABCS23Brystcancer

SABCS 2023: Blood Hormone Levels - a Key to Effective Breast Cancer Prevention in Post-Menopausal Women

/ BestPractice Nordic
SABCS23Brystcancer

BestPractice Nordic is covering SABCS 2023

/ BestPractice Nordic
SABCS23Brystcancer

SABCS 2022

Elsebeth Lynge

Does breast density affect the risk of breast cancer?

/ Elsebeth Lynge
SABCS22Brystcancer Play the Video

Lav dosis acetylsalicylsyre - Potentiel effekt mod tilbagevendende brystkræft

/ BestPractice Nordic
SABCS22Brystcancer

Kirurgiske resultater fra SABCS 2022

/ Tove Filtenborg Tvedskov
KirurgiSABCS22Brystcancer Play the Video

Meet the experts • Brystcancer • Nr. 1

Get access

Type 2 diabetes and breast cancer surgery – increased risk of postoperative complications

/ Onkologi / BestPractice Nordic

Neoadjuvant Enhertu and HER2-low breast cancer - Overall response rate of 75%

/ Onkologi / BestPractice Nordic

Trodelvy (sacituzumab govitecan) – A new effective treatment option for breast cancer

/ Onkologi / BestPractice Nordic

Interruption of endocrine therapy for pregnancy – New promising data presented at SABCS22

/ Onkologi / BestPractice Nordic

SABCS 2022 – From basic science breakthroughs to practice-changing new therapies

/ Onkologi / BestPractice Nordic

Mere fra SABCS

Per Hall

Making Primary Breast Cancer Prevention a Reality

/ Per Hall
Brystcancer Play the Video
Hope Rugo

The Potential of Trodelvy® for Patients with HR+/HER2- Metastatic Breast Cancer Patients Treated with Trodelvy®

/ Hope S. Rugo
Brystcancer Play the Video

SABCS2020: Robust survival outcome in HER2 positive metastatic breast cancer

/ Shanu Modi
HER2BrystcancerSABCS20 Play the Video

SABCS2020: Ældre patienter med brystcancer bør behandles efter guidelines

/ Tove Filtenborg Tvedskov
BrystcancerSABCS20 Play the Video

SABCS2020: Positive resultater af behandling med pembrolizumab i første linje til triple negativ brystkræft er uafhængig af valg af kemoterapi

/ BestPractice Nordic
BrystcancerSABCS20

SABCS2020: Cirkulerende tumorceller kan forudsige respons i metastatisk brystkræft

/ BestPractice Nordic
BrystcancerSABCS20

SABCS2020: Trastuzumab Deruxtecan - banebrydende behandling til HER2 positiv metastatisk brystkræft

/ BestPractice Nordic
HER2BrystcancerSABCS20

SABCS2020: CDK 4/6-hæmmeren Abemacitib givet ved tidlig brystkræft fortsætter med at vise lovende resultater

/ BestPractice Nordic
BrystcancerSABCS20
Hent flere
Back to top